Related Experiment Video
Updated: Aug 30, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors
Antony W Burgess1, Hyun-Soo Cho, Charles Eigenbrot
1Cooperative Research Centre for Cellular Growth Factors, P.O. Box 2008, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia.
Abstract:
Recent crystallographic studies have provided significant new insight into how receptor tyrosine kinases from the EGF receptor or ErbB family are regulated by their growth factor ligands. EGF receptor dimerization is mediated by a unique dimerization arm, which becomes exposed only after a dramatic domain rearrangement is promoted by growth factor binding. ErbB2, a family member that has no ligand, has its dimerization arm constitutively exposed, and this explains several of its unique properties. We outline a mechanistic view of ErbB receptor homo- and heterodimerization, which suggests new approaches for interfering with these processes when they are implicated in human cancers.
Insights
Recent studies reveal how Epidermal Growth Factor Receptor (EGFR) family kinases dimerize upon growth factor binding. This insight into ErbB receptor regulation offers new strategies for targeting cancers driven by these pathways.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Receptor tyrosine kinases (RTKs) are crucial cell signaling proteins.
- The Epidermal Growth Factor Receptor (EGFR) or ErbB family plays key roles in cell growth and cancer.
- Understanding RTK regulation is vital for developing targeted therapies.
Purpose of the Study:
- To elucidate the structural mechanisms of ErbB receptor dimerization.
- To explain the unique properties of ErbB2 due to its constitutive dimerization.
- To propose novel therapeutic strategies targeting ErbB-mediated signaling in cancer.
Main Methods:
- Analysis of recent crystallographic studies on EGFR/ErbB family receptors.
- Investigation of growth factor-induced domain rearrangements.
- Comparative analysis of ligand-dependent and ligand-independent dimerization.
Main Results:
- EGF receptor dimerization requires growth factor binding to expose a unique dimerization arm.
- ErbB2 exhibits constitutive dimerization due to a permanently exposed dimerization arm.
- These findings provide a mechanistic basis for ErbB receptor homo- and heterodimerization.
Conclusions:
- A mechanistic model for ErbB receptor dimerization has been established.
- The constitutive dimerization of ErbB2 explains its distinct biological functions.
- This research suggests new therapeutic avenues for interfering with oncogenic ErbB signaling pathways.
Related Concept Videos
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Enzyme-linked Receptors
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Amplifying Signals via Enzymatic Cascade

